These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12891856)

  • 1. [Aggressive and early combined drug therapy. Antidiabetics for prevention of myocardial infarct].
    MMW Fortschr Med; 2003 Jun; 145(25):52. PubMed ID: 12891856
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intensive therapy in type 2 diabetes. More damage than benefit?].
    Einecke D
    MMW Fortschr Med; 2008 Jun; 150(26-27):12-4. PubMed ID: 18681224
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preventing infarct in the diabetic patient. Lowering blood glucose and HbA1c are not enough].
    Reblin T; Seidel D; Stein D; Görtz A; Lander T
    MMW Fortschr Med; 2003 May; 145(19):41. PubMed ID: 12813977
    [No Abstract]   [Full Text] [Related]  

  • 4. Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments.
    Gore MO; McGuire DK
    Eur Heart J; 2011 Aug; 32(15):1832-4. PubMed ID: 21471136
    [No Abstract]   [Full Text] [Related]  

  • 5. Type 2 diabetes: target HbA1c of about 7%.
    Prescrire Int; 2009 Aug; 18(102):177. PubMed ID: 19746575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10-year follow-up of intensive glucose control in type 2 diabetes.
    Holman RR; Paul SK; Bethel MA; Matthews DR; Neil HA
    N Engl J Med; 2008 Oct; 359(15):1577-89. PubMed ID: 18784090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
    Füchtenbusch M; Hummel M
    MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
    [No Abstract]   [Full Text] [Related]  

  • 8. Individualizing glycemic targets in type 2 diabetes mellitus.
    Aron D; Conlin PR; Hobbs C; Vigersky RA; Pogach L
    Ann Intern Med; 2011 Sep; 155(5):340-1. PubMed ID: 21893635
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tough glucose reduction necessary in newly diagnosed diabetes].
    Rydén M
    Lakartidningen; 2010 Nov 10-16; 107(45):2810-4. PubMed ID: 21179867
    [No Abstract]   [Full Text] [Related]  

  • 10. [HbA1c of 6.5%. A rigid goal in diabetes therapy? (interview by Dr. Dirk Einecke)].
    Hauner H
    MMW Fortschr Med; 2008 Jun; 150(26-27):16. PubMed ID: 18683304
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetes specialists keep ACCORD data in perspective.
    Traynor K
    Am J Health Syst Pharm; 2008 Mar; 65(6):488, 490. PubMed ID: 18319488
    [No Abstract]   [Full Text] [Related]  

  • 12. [United Kingdom Prospective Diabetes Study (UKPDS): 10 years later].
    Scheen AJ; Paquot N; Lefebvre PJ
    Rev Med Liege; 2008 Oct; 63(10):624-9. PubMed ID: 19009971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose supply and insulin demand dynamics of antidiabetic agents.
    Monte SV; Schentag JJ; Adelman MH; Paladino JA
    J Diabetes Sci Technol; 2010 Mar; 4(2):365-81. PubMed ID: 20307399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Robert Koch Award for acarbose. Antidiabetic drug prevents myocardial infarct].
    MMW Fortschr Med; 2003 Feb; 145(6):59. PubMed ID: 12619367
    [No Abstract]   [Full Text] [Related]  

  • 15. Identifying the independent effect of HbA
    Prentice JC; Pizer SD; Conlin PR
    Diabet Med; 2016 Dec; 33(12):1640-1648. PubMed ID: 27279250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac risk in post-infarct patients. What allows the diabetic heart to beat longer? (interview by Dr. Judith Neumaier)].
    Mehnert H
    MMW Fortschr Med; 2006 May; 148(21):58. PubMed ID: 16796194
    [No Abstract]   [Full Text] [Related]  

  • 17. A summary of the ADVANCE Trial.
    Heller SR;
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S357-61. PubMed ID: 19875581
    [No Abstract]   [Full Text] [Related]  

  • 18. Importance of glycemic control.
    Shahady EJ
    J Fam Pract; 2011 Sep; 60(9 Suppl):S4-6. PubMed ID: 21912776
    [No Abstract]   [Full Text] [Related]  

  • 19. Metformin and risk of cardiovascular disease.
    Turner RC; Holman RR
    Cardiology; 1999; 91(3):203-4. PubMed ID: 10516415
    [No Abstract]   [Full Text] [Related]  

  • 20. Tight glycaemic control and cardiovascular disease in type 2 diabetes.
    Demssie YN; Soran H; Younis N
    Br J Hosp Med (Lond); 2009 Jan; 70(1):31-2, 34. PubMed ID: 19357575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.